Study design
Randomization in clinical trials: sequence, balance, and valid comparison
Randomization uses chance to assign participants, protecting the comparison from systematic treatment selection and supporting valid uncertainty estimates. It works as a process, not as a guarantee that every measured baseline feature will match exactly.
Educational content only. Not medical advice.
Random assignment protects the comparison
A genuinely random allocation sequence makes each assignment unpredictable according to a defined chance mechanism. This prevents investigators or participants from deliberately steering certain people into one group and, on average, balances both measured and unmeasured prognostic factors. The benefit is strongest when the sequence is generated correctly, concealed until enrollment is irreversible, and analyzed according to the randomized groups.
Simple, blocked, and stratified methods solve different design needs
Simple randomization treats assignments as independent chance events. Blocking can maintain group counts within portions of enrollment, and stratification can balance selected prognostic variables across groups. These methods remain random when implemented correctly. Predictable block size, too many sparse strata, or undocumented manual changes can weaken protection and should be reported.
Baseline imbalance can occur by chance
Randomization balances distributions in expectation, not every characteristic in every finite sample. A visible baseline difference does not by itself prove failure, and a perfectly balanced table does not prove a valid sequence. Readers should inspect the generation method, allocation process, participant flow, and any adjusted analysis planned for important prognostic variables.
Randomization does not repair every source of bias
After assignment, differential loss to follow-up, deviations from assigned intervention, unblinded outcome assessment, missing data, or selective reporting can erode validity. Randomization creates a defensible starting comparison; trial conduct and analysis must preserve it. The correct appraisal asks how the sequence was generated, who could foresee assignments, and whether exclusions occurred after assignment.
Evidence limits
- Randomization reduces systematic selection but does not guarantee identical groups in a finite sample.
- Poor concealment or post-randomization exclusions can compromise the protection.
- This guide does not select a randomization algorithm for a specific trial.
Sources and further reading
These sources ground the definitions and evidence boundaries on this page. A citation is a route for verification, not an endorsement of a product or personal use.
PubMed Central
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials
Peer-reviewed reporting guideline for randomization, allocation, masking, participant flow, outcomes, and analysis populations.
Open sourceCochrane Handbook for Systematic Reviews of Interventions
Assessing Risk of Bias in a Randomized Trial
Authoritative methods guidance on randomization, allocation concealment, deviations, missing outcomes, measurement, and selective reporting.
Open sourceU.S. Food and Drug Administration / ICH
E6(R3) Good Clinical Practice Guidance for Industry
Official good-clinical-practice principles for trial design, conduct, randomization, masking, records, and participant protection.
Open sourceCommon questions
Does randomization mean the groups will be identical?
No. It balances characteristics in expectation, while chance differences can remain in any one sample.
Is alternation a random method?
No. Alternating assignments are predictable and can permit selection into groups.
Why stratify randomization?
To improve balance on a small set of important prognostic factors while retaining chance assignment.
Continue with context
Keep building your evidence-reading skills
Explore the public PeptideSchool research library for more source-backed methods, glossaries, and evidence maps.